Crohn's disease: The case for bacteria

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 3, 1999, Pages 244-246

  Prantera, C ^a   Scribano, M L ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

Bacteria; Bradford Hill; Crohn's disease; Mycobacteria

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIUM; CROHN DISEASE; DRUG EFFICACY; ENTERITIS; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; MYCOBACTERIUM; PEPTIC ULCER; SHORT SURVEY;

ANIMALS; CROHN DISEASE; HUMANS; MYCOBACTERIUM PARATUBERCULOSIS; PARATUBERCULOSIS; RISK ASSESSMENT;

EID: 0033035146     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Levenstein S, Prantera C, Varvo V, Spinella S, Area M, Bassi O. Life events, personality, and physical risk factors in recent-onset duodenal ulcer. A preliminary study. J Clin Gastroenterol 1992;14:203-10.
2. Levenstein S. Stress and peptic ulcer: life behind Helicobacter. Br Med J 1998;316:538-41.
3. Hermon-Taylor J. Causation of Crohn's disease: the impact of clusters. Gastroenterology 1993;104:643-6.
4. Van Kruiningen HJ, Colombel JF, Cartun RW, Whitlock RH, Koopmans M, Kangro HO, et al. An in-depth study of Crohn's disease in two French families. Gastroenterology 1993;104:351-60.
5. Allan RN, Pease P, Ibbotson JP. Clustering of Crohn's disease in a Cotswold village. Q J Med 1986;59:473-8.
6. Burnam JH, Thompson H, Cooke WT, Alexander-Williams J. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut 1971;12:11-5.
7. McIlrath DC. Diverting ileostomy or colostomy in the management of Crohn's disease of the colon. Arch Surg 1971;103:308-10.
8. Harper PH, Truelove SC, Lee ECG, Kettlewell MGW, Jewell DP. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut 1983;24:106-13.
9. Rutgeerts P, Goboes K, Peelers M, Hiele M, Penninckx F, Aerts R. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
10. D' Haens GR, Geboes K, Peelers M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7.
11. Harper PH, Lee ECG, Kettlewell MGW, Bennett MK, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985;26:279-84.
12. Sartor RB. Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology 1998;114:398-407.
13. Chiodini RJ, Van Kruiningen HJ, Merkal RS. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet 1984;74:218-62.
14. Morgan KL. Johne's and Crohn's: chronic inflammatory bowel diseases of infectious aetiology? Lancet 1987;II:1017-9.
15. Glynn JR. A question of attribution. Lancet 1993;342:530-2.
16. Bradford Hill A. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
17. Burnham WR, Lennard-Jones JE, Stanford JL, Bird RG. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 1978;II:693-6.
18. Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR, Coutu JA. Characteristics of an unclassified Mycobacterium species iso-lated from patients with Crohn's disease. J Clin Microbiol 1984;20:966-71.
19. Gitnick G, Collins J, Beaman B, Brooks D, Arthur M, Imaeda T, et al. Preliminary report of isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci 1989;34:925-32.
20. Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33:890-6.
21. Thayer WR, Coutu JA, Chiodini RJ, Van Kruiningen HJ, Merkal ' RS. Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease. Dig Dis Sci 1984;29:1080-5.
22. Elsaghier A, Prantera C, Moreno C, Ivanyi J. Antibodies to mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol 1992;90:503-8.
23. Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimy-cobacterial therapy in Crohn's disease: results of a controlled trial with a multiple antibiotic regimen. Am J Gastroenterol 1994;89:513-8.
24. Schneebaum CW, Novick DM, Chabon AB, Strutynsky N, Yancovitz SR, Freund S. Terminal ileitis associated with Mycobacterium avium-intracellulare infection in a homosexual man with acquired immune deficiency syndrome. Gastroenterology 1987;92:1127-32.
25. Gray JR, Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 1989;84:1521-4.
26. Van Kruiningen HJ, Chiodini RJ, Thayer WR, Coutu JA, Merkal RS, Runnels PL. Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn's disease: a preliminary report. Dig Dis Sci 1986;31:1351-60.
27. Moss MT, Sanderson JD, Tizard MLV, Hermon-Taylor J, El-Za-atari FAK, Markesich DC, et al. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut 1992;33:1209-13.
28. Blaser MJ. Microbial causation of the chronic idiopathic inflammatory bowel diseases. Inflammatory Bowel Disease 1997;3:225-9.
29. Prantera C, Scribano ML, Berto E, Zannoni F. Antibiotic use in Crohn's disease. Biodrugs 1997;8:293-306.
30. Sutherland LR. Different patterns of Crohn's disease. In: Prantera C, Korelitz BI, editors. Crohn's disease. New York: Marcel Dekker; 1996. p. 201-15.
31. Prantera C, Berto E, Scribano ML. Mycobacteria and subgroups of patients in Crohn's disease. Ital J Gastroenterol 1991;23:49-51.
32. Abreu MT, Targan SR. The future of Crohn's disease: new developments in etiopathogenesis and therapeutics. In: Prantera C, Korelitz BI, editors. Crohn's disease. New York: Marcel Dekker; 1996. p. 561-86.
33. Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflammatory Bowel Diseases 1997;3:230-5.
34. Tabaqchali S, O'Donoghue DP, Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978;19:108-13.
35. Brown WR, Lee E. Radioimmunological measurements of bacterial antibodies: II. Human serum antibodies reactive with Bacteroides Fragilis and enterococcus in gastrointestinal and immunological disorders. Gastroenterology 1974;66:1145-53.
36. Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328-32.
37. Prantera C, Berto E, Scribano ML, Falasco G. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998;30:602-6.
38. Krok A, Jarnet G, Danielsson D. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. Scand J Gastroenterol 1981;16:569-75.
39. Burke DA, Axon ATR. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. Br Med J 1988;297:102-4.